Mimedx (MDXG) Interest Expenses (2011 - 2015)
Mimedx recorded quarterly Interest Expenses of $14000.0 in Q1 2015, up 48.6% quarter-over-quarter from $9421.0 in Q4 2014, and down 33.33% year-over-year from $21000.0 in Q1 2014.
Mimedx's Interest Expenses history runs 5 years deep, the most recent figure standing at $14000.0 for Q1 2015.
- In Q1 2015, Interest Expenses fell 33.33% year-over-year to $14000.0; the TTM figure through Dec 2015 stood at $14000.0 (down 70.82% YoY), while the FY2016 annual figure was $339000.0, up 294.19% from the prior year.
- Interest Expenses came in at $14000.0 for Q1 2015 at Mimedx, up from $9421.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $153804.0 in Q2 2012 to a low of $4527.0 in Q3 2013.
- A 5-year average of $57226.6 and a median of $21000.0 in 2014 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 251.23% in 2012 and sank 96.89% in 2013, its largest moves.
- Mimedx's Interest Expenses stood at $40373.0 in 2011, then surged by 251.23% to $141804.0 in 2012, then sank by 91.19% to $12497.0 in 2013, then fell by 24.61% to $9421.0 in 2014, then jumped by 48.6% to $14000.0 in 2015.
- According to Business Quant data, Interest Expenses over the past three periods registered $14000.0, $9421.0, and $9126.0 for Q1 2015, Q4 2014, and Q3 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 14,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 9,421.00 |
| Dec 31, 2014 | 9,421.00 |
| Sep 30, 2014 | 9,126.00 |
| Sep 30, 2014 | 9,126.00 |
| Jun 30, 2014 | 8,429.00 |
| Jun 30, 2014 | 8,429.00 |
| Mar 31, 2014 | 21,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 12,497.00 |
| Dec 31, 2013 | 12,497.00 |
| Sep 30, 2013 | 4,527.00 |
| Sep 30, 2013 | 4,527.00 |
| Jun 30, 2013 | 13,172.00 |
| Jun 30, 2013 | 13,172.00 |
| Mar 31, 2013 | 14,804.00 |
| Mar 31, 2013 | 14,804.00 |
| Dec 31, 2012 | 141,804.00 |
| Dec 31, 2012 | 141,804.00 |
| Sep 30, 2012 | 145,582.00 |
| Sep 30, 2012 | 145,582.00 |
| Jun 30, 2012 | 153,804.00 |
| Jun 30, 2012 | 153,804.00 |
| Mar 31, 2012 | 151,810.00 |
| Mar 31, 2012 | 151,810.00 |
| Dec 31, 2011 | 40,373.00 |
| Dec 31, 2011 | 40,373.00 |
| Sep 30, 2011 | 80,689.00 |
| Sep 30, 2011 | 80,689.00 |
| Jun 30, 2011 | 60,599.00 |
| Jun 30, 2011 | 60,599.00 |
| Mar 31, 2011 | 91,216.00 |
| Mar 31, 2011 | 91,216.00 |